| Literature DB >> 26535963 |
Melissa J Perry1, Heather A Young, Philippe Grandjean, Jónrit Halling, Maria Skaalum Petersen, Sheena E Martenies, Parisa Karimi, Pál Weihe.
Abstract
BACKGROUND: Although it is known that sperm aneuploidy contributes to early pregnancy losses and congenital abnormalities, the causes are unknown and environmental contaminants are suspected.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26535963 PMCID: PMC4937854 DOI: 10.1289/ehp.1509779
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Characteristics of adult Faroese men for the total sample and by cohort [n (%) or mean ± SD].
| Characteristic | Total sample ( | Birth cohort ( | Fathers cohort ( | Population register ( |
|---|---|---|---|---|
| Age (years) | 25.0 ± 4.8 | 22.6 ± 0.49 | 35.0 ± 5.6 | 24.1 ± 0.39 |
| BMI (kg/m2) | 25.3 ± 4.4 | 24.8 ± 4.1 | 26.0 ± 3.8 | 25.6 ± 4.6 |
| Semen concentration | ||||
| < 15 million/mL | 11 (12. 2) | 5 (12.5) | 1 (8.3) | 5 (13.2) |
| Motility | ||||
| < 40% motile | 2 (2.2) | 1 (2.5) | 0 (0) | 1 (2.6) |
| Morphology ( | ||||
| < 4% normal | 65 (74.7) | 27 (71.1) | 10 (83.3) | 28 (75.7) |
| Abstinence time | ||||
| ≤ 2 days | 31 (34.4) | 14 (35.0) | 2 (16.7) | 15 (39.5) |
| 3–4 days | 44 (48.9) | 16 (40.0) | 8 (66.7) | 20 (52.6) |
| ≥ 5 days | 15 (16.7) | 10 (25.0) | 2 (16.7) | 3 (7.9) |
| Smoking status ( | ||||
| Yes (current/former) | 42 (47.2) | 17 (42.5) | 7 (58.3) | 18 (48.6) |
| No | 47 (52.8) | 23 (57.5) | 5 (41.7) | 19 (51.4) |
| BMI, body mass index. | ||||
Number of nuclei scored and percent disomy for Faroese men (n = 90).
| Variable | Mean ± SD | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| Nuclei ( | 7,164 ± 4,011 | 7,098 | 4,442 | 10,093 |
| Percent X18 | 41.51 ± 6.40 | 43.09 | 38.90 | 46.08 |
| Percent Y18 | 39.50 ± 5.28 | 40.74 | 36.80 | 43.45 |
| Percent XX18 | 0.30 ± 0.26 | 0.20 | 0.12 | 0.37 |
| Percent YY18 | 0.29 ± 0.17 | 0.26 | 0.15 | 0.43 |
| Percent XY18 | 0.81 ± 0.54 | 0.54 | 0.43 | 1.03 |
| Percent total disomy | 1.39 ± 0.79 | 1.17 | 0.85 | 1.69 |
Distribution of p,p´-DDE and PCB exposures for adult Faroese men (n = 90).
| Exposure | < LOD | Geometric mean | Mean ± SD | Median | Interquartile range (Q25–Q75) |
|---|---|---|---|---|---|
| Adult ( | |||||
| 0 (0) | 0.28 | 0.51 ± 0.64 | 0.28 | 0.13–0.69 | |
| Σ4PCBs | 0 (0) | 0.37 | 0.53 ± 0.48 | 0.39 | 0.19–0.65 |
| PCB 118 | 10 (11.1) | 0.02 | 0.04 ± 0.04 | 0.02 | 0.01–0.04 |
| PCB 138 | 11 (12.2) | 0.04 | 0.12 ± 0.18 | 0.04 | 0.01–0.13 |
| PCB 153 | 0 (0) | 0.16 | 0.22 ± 0.19 | 0.17 | 0.09–0.31 |
| PCB 180 | 0 (0) | 0.10 | 0.15 ± 0.13 | 0.12 | 0.05–0.21 |
| Age 14 ( | |||||
| 0 (0) | 0.79 | 1.14 ± 1.15 | 0.72 | 0.47–1.17 | |
| Σ4PCBs | 0 (0) | 0.51 | 0.66 ± 0.52 | 0.54 | 0.32–0.84 |
| Cord blood ( | |||||
| 0 (0) | 0.45 | 0.60 ± 0.49 | 0.43 | 0.27–0.86 | |
| Σ4PCBs | 0 (0) | 0.48 | 0.59 ± 0.42 | 0.46 | 0.35–0.69 |
| Abbreviations: Σ4PCBs = sum of PCB 118, 138, 153, and 180; | |||||
Pearson correlations (p-values) for natural log–transformed organochlorine exposures in cord blood, age 14, and adult samples.
| Age 14 Σ4PCB | Adult Σ4PCB | Cord blood | Age 14 | Adult | |
|---|---|---|---|---|---|
| Cord blood Σ4PCB | 0.15 (0.41) | 0.25 (0.12) | 0.88 (< 0.0001) | 0.10 (0.58) | 0.14 (0.40) |
| Age 14 Σ4PCB | 0.75 (< 0.001) | 0.09 (0.62) | 0.77 (< 0.001) | 0.59 (0.003) | |
| Adult Σ4PCB | 0.26 (0.10) | 0.54 (0.001) | 0.93 (< 0.0001) | ||
| Cord blood | 0.22 (0.23) | 0.20 (0.21) | |||
| Age 14 | 0.52 (0.002) | ||||
| Adult | |||||
| Abbreviations: Σ4PCBs = sum of PCB 118, 138, 153, and 180; | |||||
Adjusted incidence rate ratios (95% CI) for XX, YY, XY, and total sex-chromosome disomy by p,p’-DDE and Σ4PCBs tertiles at different time points.
| Exposure | Tertile 2 | Tertile 3 |
|---|---|---|
| Cord blood | 0.34–0.54 μg/mL | > 0.54 μg/mL |
| XX18 | 0.58 (0.48, 0.71) | 1.07 (0.87, 1.32) |
| YY18 | 0.80 (0.68, 0.94) | 0.84 (0.69, 1.02) |
| XY18 | 0.67 (0.60, 0.75) | 0.97 (0.86, 1.09) |
| Total disomy | 0.68 (0.63, 0.74) | 0.94 (0.86, 1.03) |
| Age 14 | 0.54–1.08 μg/g lipid | > 1.08 μg/g lipid |
| XX18 | 1.02 (0.77, 1.35) | 1.77 (1.39, 2.26) |
| YY18 | 0.57 (0.46, 0.71) | 0.39 (0.30, 0.50) |
| XY18 | 0.85 (0.73, 0.99) | 1.45 (1.26, 1.65) |
| Total disomy | 0.79 (0.71, 0.89) | 1.19 (1.08, 1.32) |
| Adult | 0.18–0.39 μg/g lipid | > 0.39 μg/g lipid |
| XX18 | 0.90 (0.79, 1.03) | 1.52 (1.35, 1.72) |
| YY18 | 0.88 (0.78, 0.99) | 0.93 (0.82, 1.05) |
| XY18 | 1.03 (0.95, 1.12) | 1.40 (1.30, 1.51) |
| Total disomy | 0.98 (0.92, 1.04) | 1.32 (1.25, 1.35) |
| Cord blood Σ4PCBs ( | 0.40–0.59 μg/mL | > 0.59 μg/mL |
| XX18 | 1.06 (0.86, 1.31) | 1.07 (0.87, 1.31) |
| YY18 | 1.22 (1.03, 1.45) | 0.94 (0.78, 1.14) |
| XY18 | 1.08 (0.96, 1.22) | 1.16 (1.03, 1.30) |
| Total disomy | 1.09 (0.99, 1.18) | 1.09 (0.99, 1.19) |
| Age 14 Σ4PCBs ( | 0.40–0.59 μg/g lipid | > 0.59 μg/g lipid |
| XX18 | 1.21 (0.82, 1.80) | 1.93 (1.42, 2.62) |
| YY18 | 1.58 (1.12, 2.21) | 0.63 (0.46, 0.86) |
| XY18 | 1.66 (1.32, 2.08) | 2.23 (1.88, 2.65) |
| Total disomy | 1.64 (1.37, 1.92) | 1.81 (1.58, 2.06) |
| Adult Σ4PCBs ( | 0.28–0.56 μg/g lipid | > 0.56 μg/g lipid |
| XX18 | 0.76 (0.66, 0.87) | 1.22 (1.09, 1.38) |
| YY18 | 1.16 (1.03, 1.32) | 0.85 (0.74, 0.96) |
| XY18 | 0.90 (0.83, 0.98) | 1.13 (1.05, 1.22) |
| Total disomy | 0.94 (0.88, 1.00) | 1.10 (1.04, 1.16) |
| Abbreviations: Σ4PCBs = sum of PCB 118, 138, 153, and 180; | ||